Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) on Anemia and Quality of Life in Children With Cancer Undergoing Myelosuppressive Chemotherapy
NCT00261677 is registered in ClinicalTrials.gov with Ortho Biotech Products, L.P. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) on Anemia and Quality of Life in Children With Cancer Undergoing Myelosuppressive Chemotherapy
- Lead sponsor
- Ortho Biotech Products, L.P.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2000
- Completion date
- October 31, 2003
- Enrollment
- 224 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.